The Efficacy of Selected Desensitizing OTC Products: A Systematic Review.

ISRN dentistry Pub Date : 2014-03-27 eCollection Date: 2014-01-01 DOI:10.1155/2014/865761
E Talioti, R Hill, D G Gillam
{"title":"The Efficacy of Selected Desensitizing OTC Products: A Systematic Review.","authors":"E Talioti, R Hill, D G Gillam","doi":"10.1155/2014/865761","DOIUrl":null,"url":null,"abstract":"<p><p>Objectives. The aim of the present study was to review the published literature in order to identify relevant studies for inclusion and to determine whether there was any evidence on the clinical effectiveness of selected desensitizing toothpastes, calcium sodium phosphosilicate (CSPS), amorphous calcium phosphate (ACP), nanohydroxyapatite, and casein phosphopeptide-amorphous calcium phosphate (tooth mousse) on reducing dentine hypersensitivity (DH). Materials and Methods. Following a review of 593 papers identified from searching both electronic databases (PUBMED) and hand searching of relevant written journals, only 5 papers were accepted for inclusion. Results. Analysis of the included studies (3 CSPS and 2 ACP) would suggest that there may be some benefit for patients using these products for reducing DH. No direct comparative studies were available to assess all these products under the same conditions neither were there any comparative randomised controlled studies that compared at least two of these products in determining their effectiveness in treating DH. Conclusions. Due to the small number of included studies, there are limited clinical data to support any claims of clinical efficacy of these OTC products. Further studies are therefore required to determine the efficacy of these products in well-controlled RCT studies with a larger sample size. </p>","PeriodicalId":89396,"journal":{"name":"ISRN dentistry","volume":"2014 ","pages":"865761"},"PeriodicalIF":0.0000,"publicationDate":"2014-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/865761","citationCount":"27","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN dentistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/865761","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 27

Abstract

Objectives. The aim of the present study was to review the published literature in order to identify relevant studies for inclusion and to determine whether there was any evidence on the clinical effectiveness of selected desensitizing toothpastes, calcium sodium phosphosilicate (CSPS), amorphous calcium phosphate (ACP), nanohydroxyapatite, and casein phosphopeptide-amorphous calcium phosphate (tooth mousse) on reducing dentine hypersensitivity (DH). Materials and Methods. Following a review of 593 papers identified from searching both electronic databases (PUBMED) and hand searching of relevant written journals, only 5 papers were accepted for inclusion. Results. Analysis of the included studies (3 CSPS and 2 ACP) would suggest that there may be some benefit for patients using these products for reducing DH. No direct comparative studies were available to assess all these products under the same conditions neither were there any comparative randomised controlled studies that compared at least two of these products in determining their effectiveness in treating DH. Conclusions. Due to the small number of included studies, there are limited clinical data to support any claims of clinical efficacy of these OTC products. Further studies are therefore required to determine the efficacy of these products in well-controlled RCT studies with a larger sample size.

Abstract Image

选择性脱敏OTC产品的疗效:系统评价。
目标。本研究的目的是回顾已发表的文献,以确定纳入的相关研究,并确定是否有任何证据表明所选的脱敏牙膏,磷酸钠钙(CSPS),无定形磷酸钙(ACP),纳米羟基磷灰石和酪蛋白磷酸肽-无定形磷酸钙(牙慕斯)在减少牙本质过敏(DH)方面的临床有效性。材料与方法。在检索电子数据库(PUBMED)和手工检索相关书面期刊的593篇论文中,只有5篇论文被接受纳入。结果。对纳入的研究(3项CSPS和2项ACP)的分析表明,使用这些产品降低DH可能对患者有一些好处。在相同条件下,没有直接的比较研究来评估所有这些产品,也没有任何比较随机对照研究来比较至少两种产品以确定其治疗DH的有效性。结论。由于纳入的研究数量较少,支持这些OTC产品临床疗效的临床数据有限。因此,需要进一步的研究来确定这些产品在更大样本量的对照良好的RCT研究中的功效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信